131 related articles for article (PubMed ID: 18498068)
1. Fascin in ovarian epithelial tumors.
Kostopoulou E; Daponte A; Terzis A; Nakou M; Chiotoglou I; Theodosiou D; Chatzichristodoulou C; Messinis IE; Koukoulis G
Histol Histopathol; 2008 Aug; 23(8):935-44. PubMed ID: 18498068
[TBL] [Abstract][Full Text] [Related]
2. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
3. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
4. [Expression of folate receptor alpha in ovarian epithelial tumors].
Shen DH; Xie JL; Zhang YL; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer.
Daponte A; Kostopoulou E; Papandreou CN; Daliani DD; Minas M; Koukoulis G; Messinis IE
Anticancer Res; 2008; 28(3B):1905-10. PubMed ID: 18630479
[TBL] [Abstract][Full Text] [Related]
6. Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters.
Lin CK; Su HY; Tsai WC; Sheu LF; Jin JS
Dis Markers; 2008; 25(1):17-26. PubMed ID: 18776588
[TBL] [Abstract][Full Text] [Related]
7. Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma.
Khin EE; Kikkawa F; Ino K; Suzuki T; Shibata K; Kajiyama H; Tamakoshi K; Mizutani S
Int J Gynecol Pathol; 2003 Apr; 22(2):175-80. PubMed ID: 12649673
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
9. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
10. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
12. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
13. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.
Shimizu M; Nikaido T; Toki T; Shiozawa T; Fujii S
Cancer; 1999 Feb; 85(3):669-77. PubMed ID: 10091740
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.
Wang H; Rosen DG; Wang H; Fuller GN; Zhang W; Liu J
Mod Pathol; 2006 Sep; 19(9):1149-56. PubMed ID: 16729015
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma.
Puppa G; Maisonneuve P; Sonzogni A; Masullo M; Chiappa A; Valerio M; Zampino MG; Franceschetti I; Capelli P; Chilosi M; Menestrina F; Viale G; Pelosi G
Br J Cancer; 2007 Apr; 96(7):1118-26. PubMed ID: 17375048
[TBL] [Abstract][Full Text] [Related]
16. Actin bundling protein fascin expression in ovarian neoplasms: comparison of histopathologic features of tumors obtained by the first and secondary cytoreduction surgeries.
Kabukcuoglu S; Ozalp SS; Oner U; Bildirici K; Yalcin OT; Oge T; Colak E
Eur J Gynaecol Oncol; 2006; 27(2):123-8. PubMed ID: 16620052
[TBL] [Abstract][Full Text] [Related]
17. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.
Ahmed N; Riley C; Rice GE; Quinn MA; Baker MS
J Histochem Cytochem; 2002 Oct; 50(10):1371-80. PubMed ID: 12364570
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
Hu YQ; Liu YJ
Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.
Hu W; McCrea PD; Deavers M; Kavanagh JJ; Kudelka AP; Verschraegen CF
Clin Exp Metastasis; 2000; 18(1):83-8. PubMed ID: 11206843
[TBL] [Abstract][Full Text] [Related]
20. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.
Behrens P; Rothe M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2001 Aug; 8(2):149-54. PubMed ID: 11445865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
